Senate Appropriations Bill Provides Boost to Fight Against AMR
IDSA is pleased to see that critical new investments to strengthen the federal fight against antimicrobial resistance were included in the fiscal year 2023 Labor, Health and Human Services appropriations bill released July 28. The bill proposes a $30 million increase in funding for the Centers for Disease Control and Prevention’s AMR efforts that will provide a much-needed boost to surveillance, prevention and stewardship. Notably, the bill also endorses the proposal included in the President’s budget to rejuvenate antimicrobial research and development by delinking federal payments for antimicrobials from their volume of sales. This approach aligns with the bipartisan PASTEUR Act, which IDSA urges Congress to enact swiftly.
Antimicrobial-resistant infections and deaths increased by 15% during the COVID-19 pandemic, and these investments are needed to provide clinicians with the tools necessary to save lives and protect the many modern medical advances that rely upon antibiotics.
Daniel P. McQuillen, MD, FIDSA -- President, Infectious Diseases Society of America
The Infectious Diseases Society of America (IDSA) is a community of over 12,000 physicians, scientists and public health experts who specialize in infectious diseases. Our mission is to improve the health of individuals, communities, and society by promoting excellence in patient care, education, research, public health and prevention relating to infectious diseases. Learn more at https://www.idsociety.org.